HGH vs Sermorelin vs CJC-1295 — Growth Hormone Approach Comparison
QSC Research Guide
HGH vs Sermorelin vs CJC-1295 — Growth Hormone Approach Comparison
Three distinct approaches to GH axis research: direct exogenous HGH, or stimulating the pituitary via GHRH analogues (Sermorelin, CJC-1295). Each produces different GH release patterns, IGF-1 profiles, and feedback dynamics.
Side-by-Side Comparison
Attribute
HGH (Somatropin)
Sermorelin
CJC-1295 (No DAC)
Mechanism class
Direct GH receptor agonist
GHRH(1-29) analogue
DPP-IV-resistant GHRH analogue
Receptor targets
GH receptor (GHR)
GHRH receptor (pituitary)
GHRH receptor
Half-life
~15-20 min (SC ~3.5h)
~10-20 min
~30 min (longer than Sermorelin)
Key advantage
Direct supraphysiological GH levels; predictable pharmacokinetics; bypasses pituitary entirely
Preserves pituitary feedback — GH rises remain within physiological range; still FDA-approved analogue
DPP-IV resistance extends action; stronger and more sustained GHRH-R stimulation than native Sermorelin
Best for research
Direct GHR agonism research, IGF-1 upregulation, body composition studies
HGH provides direct, controllable GHR activation bypassing pituitary — most predictable for IGF-1 research. Sermorelin and CJC-1295 both stimulate pituitary GH secretion but maintain natural feedback loops — producing more physiological GH release patterns. CJC-1295 produces stronger, more sustained GHRH-R stimulation than Sermorelin due to DPP-IV resistance.
Frequently Asked Questions
What is the key difference between HGH and GH secretagogues?
Direct HGH administration bypasses pituitary, producing immediate GHR activation regardless of endogenous GH status — useful for supraphysiological GH research. GHRH analogues (Sermorelin, CJC-1295) stimulate pituitary to release endogenous GH — maintaining feedback and producing more physiological GH patterns.
Does Sermorelin preserve more physiological pulsatility than CJC-1295?
Both preserve pulsatility better than direct HGH. Sermorelin, being native GHRH(1-29), has a very short half-life (~10 min) producing shorter GH pulses. CJC-1295’s DPP-IV resistance extends action, producing larger and more sustained GH pulses while still maintaining pulsatile vs. the flat GH elevation of direct HGH.
Which is most studied for IGF-1 research?
HGH produces the most predictable and controllable IGF-1 elevation — directly stimulating liver IGF-1 production via GHR. GHRH analogues stimulate pituitary GH which then drives IGF-1, but the relationship is less direct and subject to pituitary responsiveness.
Research Use Only: All QSC compounds are sold strictly for laboratory research purposes only. Not for human consumption, veterinary use, or any other application. Researchers are responsible for compliance with local regulations.
QSC Network
Compound reference, COA verification, and regional warehouse information across the QSC network.
